Cargando…
Toward the Treatment of Inherited Diseases of the Retina Using CRISPR-Based Gene Editing
Inherited retinal dystrophies [IRDs] are a common cause of severe vision loss resulting from pathogenic genetic variants. The eye is an attractive target organ for testing clinical translational approaches in inherited diseases. This has been demonstrated by the approval of the first gene supplement...
Autores principales: | Hernández-Juárez, Jennifer, Rodríguez-Uribe, Genaro, Borooah, Shyamanga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517184/ https://www.ncbi.nlm.nih.gov/pubmed/34660621 http://dx.doi.org/10.3389/fmed.2021.698521 |
Ejemplares similares
-
Commentary: CRISPR gene editing for inherited retinal dystrophies: Towards clinical translation
por: Bansal, Mayank, et al.
Publicado: (2022) -
The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases
por: Abdelnour, Sameh A., et al.
Publicado: (2021) -
Assessing the validity of a cross-platform retinal image segmentation tool in normal and diseased retina
por: Alex, Varsha, et al.
Publicado: (2021) -
In Vivo Applications of CRISPR-Based Genome Editing in the Retina
por: Yu, Wenhan, et al.
Publicado: (2018) -
Late-Onset Retinal Degeneration: Clinical Perspectives
por: Lando, Leonardo, et al.
Publicado: (2022)